Only shorts ask for the CEO to be replaced after the first successful nGBM trial in nearly 2 decades and first successful rGBM trial in nearly 3 decades. Success where 400+ others have failed. Approvable data.
I'm holding and waiting for your end of year $15 target price mr. scotty!